Hudson Bay Capital Management’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-713,743
Closed -$1.42M 1182
2022
Q3
$1.42M Hold
713,743
0.01% 805
2022
Q2
$1.54M Hold
713,743
0.01% 847
2022
Q1
$2.65M Hold
713,743
0.04% 621
2021
Q4
$4.4M Buy
+713,743
New +$8.15M 0.04% 387

Other funds holding LIAN

Hudson Bay Capital Management's LIAN Position: Q4 2022 in Review

Hudson Bay Capital Management sold out of LianBio American Depositary Shares (LIAN) in Q4 2022, closing a stake of 713,743 shares — an estimated $1.42M sold.

Hudson Bay Capital Management first reported a position in LIAN in Q4 2021 and held it in 4 quarters. The position peaked at $4.4M in Q4 2021. 40 funds tracked by Wall St. Rank hold LIAN as of Q4 2022.

  • Hudson Bay Capital Management reported no remaining LianBio American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Hudson Bay Capital Management sold 713,743 LianBio American Depositary Shares shares in Q4 2022, an estimated $1.42M.
  • Hudson Bay Capital Management first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 4 quarters.
  • Hudson Bay Capital Management's LianBio American Depositary Shares position peaked at $4.4M in Q4 2021.
  • 40 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2022.

Based on Hudson Bay Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.